Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Business Insights: Page 2
Bristol Myers Squibb to reduce workforce in restructuring plan
By
LabPulse.com staff writers
As part of a restructuring plan intended to cut $1.5 billion in costs, Bristol Myers Squibb plans to cut about 6% of its workforce, according to the firm.
April 25, 2024
U.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuit
By
LabPulse.com staff writers
The Patents Court of the High Court of England and Wales has ruled that two patents owned by Bio-Techne are invalid, rejecting a patent infringement lawsuit filed by Bio-Techne/ACD in the U.K. against Molecular Instruments.
April 24, 2024
Bio-Techne files EU patent infringement suit against Molecular Instruments
By
LabPulse.com staff writers
Life sciences company Bio-Techne has filed a lawsuit against Molecular Instruments in the pan-European Unified Patent Court, alleging patent infringement of its RNAscope in situ hybridization technology.
April 23, 2024
Fujifilm Diosynth Biotechnologies confirms layoffs
By
LabPulse.com staff writers
Fujifilm Diosynth Biotechnologies confirmed a restructure that will result in the layoff of 240 employees.
April 19, 2024
Bruker to acquire NanoString for $392.6M
By
LabPulse.com staff writers
NanoString has reached an agreement with Bruker in which Bruker will purchase substantially all of NanoString's assets for approximately $392.6 million in cash, as well as assume certain NanoString liabilities.
April 18, 2024
DermTech receives delisting warning from Nasdaq
By
LabPulse.com staff writers
Melanoma diagnostics company DermTech announced that it has received a delisting warning from Nasdaq.
April 17, 2024
Nightingale Health to open U.S. lab, collaborate with Englander Institute at Weill Cornell
By
LabPulse.com staff writers
Preventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.
April 17, 2024
Co-Diagnostics opens manufacturing facility in Utah
By
LabPulse.com staff writers
Molecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.
April 16, 2024
OraSure discloses cybersecurity breach
By
LabPulse.com staff writers
OraSure Technology disclosed a cybersecurity incident involving data theft that occurred in late March.
April 15, 2024
Roche, Lilly Alzheimer's blood test granted FDA breakthrough device designation
By
LabPulse.com staff writers
The Alzheimer's blood test developed through a collaboration between Roche and Lilly has been granted a breakthrough device designation by the U.S. Food and Drug Administration (FDA).
April 11, 2024
European Commission approves Illumina's plan to divest Grail
By
LabPulse.com staff writers
The European Commission has approved Illumina's plan to divest multicancer early detection test maker Grail under the European Union Merger Regulation adopted by the EC in October 2023.
April 12, 2024
Roche's breast cancer CDx receives CE Mark
By
LabPulse.com staff writers
Roche has received the CE Mark for the first companion diagnostic (CDx) test to identify patients with HER2-low metastatic breast cancer who may be eligible for treatment with Enhertu.
April 10, 2024
Previous Page
Page 2 of 178
Next Page